Moonfire Ventures invests in Pharosyn
Funding Provisional 92% confidence first seen
London-based Pharosyn raised a $3 million seed round led by Moonfire Ventures, with Entrepreneurs First, Transpose Platform, and General Advance also participating. The article says the funding is for hiring and scaling its AI system for pharmaceutical commercial and competitive intelligence, including work on AI hallucination mitigation. This matters because it supports faster, traceable reporting for pharma pricing, market access, and portfolio decisions.
The deal
Pharosyn $3M Seed · announced 2 Sep 2026
Investors Moonfire Ventures
Deal terms as reported in the coverage below.